It’s the most common liver ailment in the country, but treatment is limited to diet and exercise. Researchers are now looking ...

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

I didn’t expect to feel as excited about my 60th birthday as I had been about my 13th. In the baggage of my experiences, there are too many broken hearts and broken promises for the joyous ...

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...

Colorectal liver metastases (CRLM), cancer that has spread from the colon or rectum to the liver, have a deadly reputation. Due to its pervasive spread, typical cancer treatments like chemotherapy and ...

Liver cancer is considered one of the rarer types of cancer in Germany, but the number of new cases is increasing. The insidious disease often develops slowly and remains undetected in its early ...

HCC has a high mortality rate and a rising incidence in the US, imposing substantial healthcare costs and financial hardships on patients. Although the use of immune checkpoint inhibitors has improved ...

Mark Burkholder tells PEOPLE he and his late wife, Paige, wanted to document the "raw and honest" reality of terminal cancer Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

Please provide your email address to receive an email when new articles are posted on . Veterans with cirrhosis who had any mental health disorder had a significantly higher risk for liver cancer than ...

Based on the initial results of CheckMate 9DW, NIVO + IPI is approved in numerous countries as first-line treatment for patients with unresectable HCC. At a pre-planned interim analysis, with 35 ...

Trish Lalor does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...